SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-047180
Filing Date
2021-04-06
Accepted
2021-04-06 17:28:47
Documents
5
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212454-1_def14a.htm DEF 14A 1561000
2 GRAPHIC lg_rigelreg-4c.jpg GRAPHIC 67243
3 GRAPHIC sg_dollyvance-bw.jpg GRAPHIC 8169
4 GRAPHIC tm212454d1-pc_01proxybw.jpg GRAPHIC 1711312
5 GRAPHIC tm212454d1-pc_02proxy4c.jpg GRAPHIC 1230423
  Complete submission text file 0001104659-21-047180.txt   5704987
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29889 | Film No.: 21810055
SIC: 2834 Pharmaceutical Preparations